Literature DB >> 780279

Inhibition of phagocytosis by cryptococcal polysaccharide: dissociation of the attachment and ingestion phases of phagocytosis.

T R Kozel, R P Mastroianni.   

Abstract

The effects of cryptococcal polysaccharide and selected serum factors on (i) the attachment of Cryptococcus neoformans to macrophages and (ii) the subsequent ingestion of yeast cells by the macrophages were investigated. Percent attachment was measured after incubation of yeast cells with macrophages at 4 C. Percent engulfment was determined after incubation of yeast cells and macrophages at 37 C. Nonencapsulated yeast cells readily attached to macrophages at the low temperature and were engulfed at a high rate at 37 C, whereas encapsulated yeast cells attached to macrophages at low rates and were engulfed at low rates. Addition of varying doses of purified cryptococcal polysaccharide to nonencapsulated yeast cells inhibited attachment at approximately the same concentration of polysaccharide required for inhibition of engulfment. Nonencapsulated yeast cells that attached to macrophages at 4 C were eluted from the macrophages by addition of purified cryptococcal polysaccharide to the incubation medium. Heat-labile opsonins were not required for attachment of yeast cells to macrophages, but they were necessary for maximal initial rates of phagocytosis. Heat-stable components of serum facilitated attachment of cryptococci, but their most important function appeared to be triggering the ingestion of attached yeast. Specific antiserum had no effect on the attachment and engulfment of nonencapsulated cryptococci, and the antiserum produced only a small enhancement of the engulfment of encapsulated cryptococci.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 780279      PMCID: PMC420844          DOI: 10.1128/iai.14.1.62-67.1976

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  20 in total

1.  The role of the classical and alternate complement pathways in host defenses against Cryptococcus neoformans infection.

Authors:  R D Diamond; J E May; M A Kane; M M Frank; J E Bennett
Journal:  J Immunol       Date:  1974-06       Impact factor: 5.422

2.  Factors influencing killing of Cryptococcus neoformans by human leukocytes in vitro.

Authors:  R D Diamond; R K Root; J E Bennett
Journal:  J Infect Dis       Date:  1972-04       Impact factor: 5.226

3.  Induction of humoral antibody response by soluble polysaccharide of Cryptococcus neoformans.

Authors:  T R Kozel; J Cazin
Journal:  Mycopathol Mycol Appl       Date:  1974-10-15

4.  Further studies on acquired resistance to murine cryptococcosis: enhancing effect of Bordetella pertussis.

Authors:  I Abrahams
Journal:  J Immunol       Date:  1966-03       Impact factor: 5.422

5.  Immunofluorescence studies of reactions at the Cryptococcal capsule.

Authors:  M B Goren; J Warren
Journal:  J Infect Dis       Date:  1968-04       Impact factor: 5.226

6.  Particle recognition by cultivated macrophages.

Authors:  M Rabinovitch; M J De Stefano
Journal:  J Immunol       Date:  1973-03       Impact factor: 5.422

7.  Elution of macrophage-bound immunoglobulins by temperature changes in vitro.

Authors:  I R Tizard
Journal:  Immunology       Date:  1972-01       Impact factor: 7.397

8.  Intracellular fate of Cryptococcus neoformans.

Authors:  J R Tacker; F Farhi; G S Bulmer
Journal:  Infect Immun       Date:  1972-08       Impact factor: 3.441

9.  Quantitative studies of phagocytosis. Kinetic effects of cations and heat-labile opsonin.

Authors:  T P Stossel
Journal:  J Cell Biol       Date:  1973-08       Impact factor: 10.539

10.  THE DIFFERENTIATION OF MONONUCLEAR PHAGOCYTES. MORPHOLOGY, CYTOCHEMISTRY, AND BIOCHEMISTRY.

Authors:  Z A COHN; B BENSON
Journal:  J Exp Med       Date:  1965-01-01       Impact factor: 14.307

View more
  72 in total

Review 1.  Immunity in cryptococcosis: an overview.

Authors:  R A Fromtling; H J Shadomy
Journal:  Mycopathologia       Date:  1982-03-19       Impact factor: 2.574

2.  Cryptococcal capsular polysaccharide clearance in nonimmune mice.

Authors:  H G Muchmore; E N Scott; F G Felton; R A Fromtling
Journal:  Mycopathologia       Date:  1982-04-23       Impact factor: 2.574

3.  Resistance to challenge and macrophage activity in mice previously vaccinated with formalin-killed Cryptococcus neoformans.

Authors:  D M Anderson; M A Dykstra
Journal:  Mycopathologia       Date:  1984-06-30       Impact factor: 2.574

Review 4.  Flying under the radar: Histoplasma capsulatum avoidance of innate immune recognition.

Authors:  Stephanie C Ray; Chad A Rappleye
Journal:  Semin Cell Dev Biol       Date:  2018-03-21       Impact factor: 7.727

5.  Involvement of C3a and C5a in interleukin-8 secretion by human polymorphonuclear cells in response to capsular material of Cryptococcus neoformans.

Authors:  A Vecchiarelli; C Retini; A Casadevall; C Monari; D Pietrella; T R Kozel
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

6.  Host defense in Cryptococcosis. III. In vivo alteration of immunity.

Authors:  J R Graybill; L Mitchell
Journal:  Mycopathologia       Date:  1979-12-28       Impact factor: 2.574

7.  Non-encapsulated variant of Cryptococcus neoformans. II. Surface receptors for cryptococcal polysaccharide and their role in inhibition of phagocytosis by polysaccharide.

Authors:  T R Kozel
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

8.  Systematic genetic analysis of virulence in the human fungal pathogen Cryptococcus neoformans.

Authors:  Oliver W Liu; Cheryl D Chun; Eric D Chow; Changbin Chen; Hiten D Madhani; Suzanne M Noble
Journal:  Cell       Date:  2008-10-03       Impact factor: 41.582

9.  Relationship between cell surface composition, adherence, and virulence of Candida albicans.

Authors:  J McCourtie; L J Douglas
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

10.  The glycan-rich outer layer of the cell wall of Mycobacterium tuberculosis acts as an antiphagocytic capsule limiting the association of the bacterium with macrophages.

Authors:  Richard W Stokes; Raymond Norris-Jones; Donald E Brooks; Terry J Beveridge; Dan Doxsee; Lisa M Thorson
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.